维普中文期刊产品整合服务
890篇 您的检索式:作者名="YAMADA C"
    题名 作者 年代 出处 被引量
1蛋白酶激活受体2在载脂蛋白E缺陷小鼠的血管炎症和动脉粥样硬化中发挥关键作用显示文摘凝血系统与血管炎症密切相关,尽管其潜在机制仍不清楚。最近的研究结果表明,蛋白酶激活受体(protease-activated receptor,PAR)2——活化因子X(activated factor X,FXa)的主要受体之一——在血管细胞和白细胞中均有表达,这提示PAR-2可能参与炎症性疾病的发病机制。Hara T Phuong PT Fukuda D Yamaguchi K Murata C Nishimoto S Yagi S Kusunose K Yamada H Soeki T Wakatsuki T Imoto I Shimabukuro M Sata M 刘青 叶鹏 2018中华高血压杂志2018,26,6:11
2Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models显示文摘AIM To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma(HCC) patients after liver transplant.METHODS BALAD score and BALAD-2 class are derived from bilirubin, albumin, alpha-fetoprotein(AFP), Lens culinaris agglutinin-reactive AFP(AFP-L3), and des-gammacarboxyprothrombin(DCP). Pre-transplant AFP, AFP-L3 and DCP were measured in 113 patients transplanted for HCC from 2000 to 2008. Hazard ratios(HR) for recurrence and death were calculated. Univariate and multivariate regression analyses were conducted. C-statistics were used to compare biomarker-based to predictive models. RESULTS During a median follow-up of 12.2 years, 38 patients recurred and 87 died. The HRs for recurrence in patients with elevated AFP, AFP-L3, and DCP defined by BALAD cut-off values were 2.42(1.18-5.00), 1.86(0.98-3.52), and 2.83(1.42-5.61), respectively. For BALAD, the HRs for recurrence and death per unit increased score were 1.48(1.15-1.91) and 1.59(1.28-1.97). For BALAD-2, the HRs for recurrence and death per unit increased class were 1.45(1.06-1.98) and 1.38(1.09-1.76). For recurrence prediction, the combination of three biomarkers had the highest c-statistic of 0.66 vs. 0.64, 0.61, 0.53, and 0.53 for BALAD, BALAD-2, Milan, and UCSF, respectively. Similarly, for death prediction, the combination of three biomarkers had the highest c-statistic of 0.66 vs 0.65,0.61, 0.52, and 0.50 for BALAD, BALAD-2, Milan, and UCSF. A new model combining biomarkers with tumor size at the time of transplant(S-LAD) demonstrated the highest predictive capability with c-statistics of 0.71 and 0.69 for recurrence and death. CONCLUSION BALAD and BALAD-2 are valid in transplant HCC patients, but less predictive than the three biomarkers in combination or the three biomarkers in combination with maximal tumor diameter(S-LAD).Nicha Wongjarupong Gabriela M Negron-Ocasio Roongruedee Chaiteerakij Benyam D Addissie Essa A Mohamed Kristin C Mara William S Harmsen J Paul Theobald Brian E Peters Joseph G Balsanek Melissa M Ward Nasra H Giama Sudhakar K Venkatesh Denise M Harnois Michael R Charlton Hiroyuki Yamada Alicia Algeciras-Schimnich Melissa R Snyder Terry M Therneau Lewis R Roberts 2018World Journal of Gastroenterology2018,24,12:5
3Notes on Extended-Range Atmospheric Prediction in the Northern Hemisphere Winter显示文摘NotesonExtended-RangeAtmosphericPredictionintheNorthernHemisphereWinterShingoYamadaForecastDivision,JapanMeteorologicalAgency...Shingo Yamada Forecast Division, Japan Meteorological Agency, Tokyo, 100, Japan Shuhei Maeda Administration Division, Climate and Marine Department, Japan Meteorological Agency, Tokyo, 100, Japan K. Gambo c/o Department of Earth and Planetary Physi 1997Advances in Atmospheric Sciences1997,14,1:3
4Processing of biocompatible porous Ti and Mg显示文摘WEN C E MABUCHI M Yamada Y 2001Scripta Materialia2001,45,10:1
5Analysis of laminate strength and its distribution显示文摘Yamada S E Sun C T 1978J Compos Mater1978,12,:1
6Ectopic expression of Oct4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues显示文摘Hochedlinger K Yamada Y Beard C 2005Cell2005,121,3:1
7Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 ( CFEOM3 ) 显示文摘Yamada K Chan WM Andrews C Bosley TM Sener EC Zwaan JT 2004Invest Ophthalmol Vis Sci2004,45,7:1
8Predictors of progression from prehypertension to hypertension in Japanese men 显示文摘Tomiyama H Matsumoto C Yamada J 2009Am J Hypertens2009,22,11:1
9Expression of basic fibroblast growth factor and fibroblast growth factor receptor 1 in the experimental retinal vein occlusion model显示文摘Matsushima M Yamada H Yamamoto C 1997Nippon Ganka Gakkai Zasshi1997,101,:1
10Pilots with non-insulin-dependent diabetes mellitus can self-monitor their blood glucose显示文摘Tajima N Yamada C Asukata I 1989Aviat Space Environ Med1989,60,:1
11Processing of biocompatible porous Ti and Mg显示文摘WEN C E MABUCHI M YAMADA Y SHIMOJIMA K CHINO Y ASAHINA T 2001Scripta Materialia2001,45,10:1
12Optimized LiFeP04 for lithiumbattery cathodes 显示文摘YAMADA A CHUNGS C 2001J Electrochem Soc2001,148,3:1
13Processing and mechanical properties of autogenous titanium implant materials 显示文摘WEN C E YAMADA ~ SHIMOJIMA K CHINO Y ASAHINA T MABUCHI M 2002Journal of Materials Science: Materials in Medicine2002,13,4:1
14查看详情显示文摘Yamada C Hirota E 0,,:1
15Ectopic expression of Oct-4 blocks progenitor-cel differentiation and causes dysplasia in epithelial tissues显示文摘Hochedlinger K Yamada Y Beard C 0,,03:1
16Interferongamma production by neutrophils during bacterial pneumonia in mice显示文摘Yamada M Gomez J C Chugh P E 2011Am J Respir Crit Care Med2011,183,10:1
17The murine glucagon-like peptide-1 receptor is essential for control of bone resorption显示文摘Yamada C Yamada Y Tsukiyama K 2008Endocrinology2008,149,2:1
18Optimized LiFePO4 for lithium battery cathodes 显示文摘Yamada A Chung S C Hinokuma K 2001Electrochem Soc2001,148,3:1
19Bilateral lobectomy excluding the caudate lobe for giant mesenchymal hamartoma of the liver显示文摘Shuto T Kinoshita H Yamada C 1993Surgery1993,113,2:1
20Processing of biocompatible porous Ti and Mg 显示文摘WEN C E MABUCHI M YAMADA Y SHIMOJIMA K CHINO Y ASAHINA T 2001Scripta Materialia2001,45,10:1
返回顶部 每页显示:
共45页 首页 上一页 第1页 下一页 末页 /45 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费